| Literature DB >> 19327577 |
Andrea Bacigalupo1, Jakob Passweg.
Abstract
Acquired severe aplastic anemia can be treated successfully with either immunosuppressive therapy or bone marrow transplantation. Although immunosuppressive therapy can be readily administered to all patients, it is not a curative approach and is associated with a higher risk of clonal evolution than is transplantation, which yields rapid and long-lasting hematologic remission. This article reviews the key diagnostic and prognostic factors that influence the choice of therapy in patients with acquired aplastic anemia.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19327577 DOI: 10.1016/j.hoc.2009.01.005
Source DB: PubMed Journal: Hematol Oncol Clin North Am ISSN: 0889-8588 Impact factor: 3.722